| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Cadila Healthcare Limited (NSE: CADILAHC)
CADILAHC Technical Analysis
1
| As on N/A CADILAHC SHARE Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS. |
CADILAHCSHARE Price
| Open | N/A | Change | Price | % |
| High | N/A | 1 Day | N/A | N/A |
| Low | N/A | 1 Week | N/A | N/A |
| Close | N/A | 1 Month | N/A | N/A |
| Volume | N/A | 1 Year | N/A | N/A |
| 52 Week High N/A | 52 Week Low N/A | ||||
NSE INDIA Most Active Stocks
| IDEA | 12.95 | -1.52% |
| YESBANK | 23.95 | 0.00% |
| ONGC | 283.15 | 1.18% |
| EXIDEIND | 459.80 | 12.41% |
| NHPC | 91.20 | 2.53% |
| IDFCFIRSTB | 82.70 | -0.06% |
| PNB | 128.55 | -3.24% |
| ZOMATO | 186.45 | -0.98% |
| DHANI | 48.00 | 15.38% |
| TATASTEEL | 160.05 | -0.50% |
NSE INDIA Top Gainers Stocks
| DSSL | 1131.95 | 20.00% |
| HINDMOTORS | 21.95 | 19.95% |
| WABAG | 923.90 | 15.50% |
| DHANI | 48.00 | 15.38% |
| BHAGERIA | 185.45 | 15.15% |
| AKASH | 40.95 | 13.43% |
| MARKSANS | 176.70 | 13.38% |
| EXIDEIND | 459.80 | 12.41% |
| JAGSNPHARM | 321.45 | 11.89% |
| SOTL | 542.55 | 10.85% |
NSE INDIA Top Losers Stocks
| CADILAHC Daily Charts |
CADILAHC Intraday Charts |
Whats New @ Bazaartrend |
CADILAHC Free Analysis |
|
|
CADILAHC Important Levels Intraday
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE |
CADILAHC Target April 2024
| 4th UP Target | |
| 3rd UP Target | |
| 2nd UP Target | |
| 1st UP Target | |
| 1st DOWN Target | |
| 2nd DOWN Target | |
| 3rd DOWN Target | |
| 4th DOWN Target |
CADILAHC Weekly Target
| 4th UP Target | |
| 3rd UP Target | |
| 2nd UP Target | |
| 1st UP Target | |
| 1st DOWN Target | |
| 2nd DOWN Target | |
| 3rd DOWN Target | |
| 4th DOWN Target |
CADILAHC Target2024
| 4th UP Target | |
| 3rd UP Target | |
| 2nd UP Target | |
| 1st UP Target | |
| 1st DOWN Target | |
| 2nd DOWN Target | |
| 3rd DOWN Target | |
| 4th DOWN Target |
Cadila Healthcare Limited ( NSE INDIA Symbol : CADILAHC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CADILAHC Synopsis Technicals View
| 50 Day EMA |
Close is Below EMA 50 (Short Term) |
Bearish | |
| 100 Day EMA | Close is Below EMA 100 (Mid Term) | Bearish | |
| 200 Day EMA | Close is Below EMA 200 (Long Term) | Bearish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is 48.44 | Sideways | |
| MFI (14) | MFI is 53.05 | Sideways | |
| CCI (20) | CCI is -12.84 | Sideways | |
| WILLIAM %R (14) | William %R is -20.71 | Sideways | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Short Sell | 203.33 | |
| 10 Day Avg Volume | Traded -22.11 % Less then 10 Day Average Volume | ||
CADILAHC Other Details
| Segment | EQ | |
| Market Capital | 522875207680.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
CADILAHC Address
 |
||
CADILAHC Latest News
CADILAHC Business Profile
Cadila Healthcare Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It offers finished dosage human formulations comprising generics, branded generics, and specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; animal healthcare products; and consumer wellness products. The company provides products in the therapeutic areas of pain management, neurology, liver diseases, and other areas. It also offers consumer wellness products, such as SugarFree and Sugarlite; Complan; EverYuth, a range of skincare products; Nycil, a prickly heat powder; Glucon-D glucose powder; Sampriti Ghee; Nutralite; and various other products. In addition, the company is developing drugs in the areas of oncology, autoimmune disease, nephrology, ophthalmology, inflammation, rheumatology, hepatology, infectious disease, etc. Further, it offers animal healthcare products for various therapeutic areas, such as anti-bacterial, NSAIDs, anti-mastitis, tonics, and poultry vaccines. The company also engages in the retail pharmacy, and manpower supply and administration activities. Cadila Healthcare Limited was founded in 1952 and is based in Ahmedabad, India. Address: Zydus Corporate Park, Ahmedabad, India, 382481
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service